Long-Term Dual Antiplatelet Therapy for Patients With Previous MI

Study Questions:

What are the cardiovascular benefits and risks of dual antiplatelet therapy (DAPT) beyond 1 year for secondary prevention in high-risk patients with a prior myocardial infarction (MI)?